Search clinical trials for: ALKS 37

Total 262 results

Alkermes, Inc.

Completed

ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)

Opioid-induced Constipation

United States
Alkermes, Inc.

Completed

ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)

OIC

United States
Alkermes, Inc.

Completed

ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

Opioid-induced Constipation

United States
Alkermes, Inc.

Completed

A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia

Schizophrenia

United States
Alkermes, Inc.

Completed

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Schizophrenia

United States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
Alkermes, Inc.

Completed

An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Schizophrenia

United States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
Association de Recherche en Physiopathologie Respiratoire
GlaxoSmithKline; Soladis; Interlis

Unknown

The PAH Disability and Bothersomeness Questionnaire (PAH-DBoQ)

Pulmonary Arterial Hypertension (PAH)

France
Alkermes, Inc.

Completed

Pharmacokinetics and Safety of ALKS 5461 in Healthy Subjects and Subjects With Hepatic Impairment and Normal Hepatic Function

Hepatic Impairment

United States
Alkermes, Inc.

Completed

A Water Consumption Study of ALKS 5461 in Healthy Volunteers

Healthy

United States
Imperial College London

Not yet recruiting

Novel Mucosal Correlates Of RSV Protection In Older Adults (CHIRP01)

Respiratory Tract Infections

United Kingdom
Marcela V. Maus, M.D.,Ph.D.

Completed

CAR-37 T Cells In Hematologic Malignancies

Lymphoma | Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Leukemia | Lymphoma, T-Cell | Hematologic Malignancy

United States
Hepatopancreatobiliary Surgery Institute of Gansu...

Not yet recruiting

Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma

Cholangitis

China
Alkermes, Inc.

Recruiting

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (Vibrance-1)

Narcolepsy Type 1

United States
Alkermes, Inc.

Terminated

Phase 1 ALKS 1140 in Healthy Adults

Central Nervous System Diseases

Australia
Imperial College London
Wellcome Trust

Completed

The Development of a Human Model of Respiratory Syncytial Virus Infection

Respiratory Syncytial Virus Infections | Respiratory Viral Infections

United Kingdom
Alkermes, Inc.

Completed

A Study of ALKS 5461 in Healthy Volunteers

Pharmacokinetics

United States
Alkermes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine

Cocaine Abuse

United States
Imperial College London
Medical Research Council; Wellcome Trust; National Institute for Health Research...

Terminated

A Study of Protective Immunity Against RSV and Influenza in Experimental Human Challenge of Volunteers

Influenza, Human | Respiratory Syncytial Virus Infections

United Kingdom
Maastricht University Medical Center

Completed

Contrast Media Temperature and Patient Comfort in CT of the Abdomen (CATCHY)

Abdomen | Temperature | Contrast Media | Comfort

Netherlands
Mural Oncology, Inc

Recruiting

Nemvaleukin Alfa (ALKS 4230) Monotherapy in Patients With Advanced Cutaneous Melanoma or Advanced Mucosal Melanoma - ARTISTRY-6 (ARTISTRY-6)

Cutaneous Melanoma | Mucosal Melanoma

United States, Australia, Canada, Italy, Korea, Republic of, Spain, Taiwan, United Kingdom
Ege University

Recruiting

Investigation of the Effect of Distention Medium Temperature on Image Quality, Hyponatremia Risk, and Post-operative Pain in Operative Hysteroscopy

Post-operative Pain

Turkey
Merve Erkmen Almaz
Kırıkkale University

Completed

Salivary TAS, TOS, LL-37 and Dental Status in Passive Smoking Children

Dental Caries | Children | Oxidative Stress | Passive Smoking
Ibn Sina Hospital

Completed

Incubator Temperature for Culturing Human Embryos

Embryo Culture

Egypt
Biogen
Alkermes, Inc.

Completed

A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1

Multiple Sclerosis

United States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
Alkermes, Inc.

Completed

A Long-Term Safety Study of ALKS 5461

Major Depressive Disorder

United States, Canada, Germany, Puerto Rico, Bulgaria, Australia, Poland, Hungary
Alkermes, Inc.

Completed

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study

Major Depressive Disorder

United States, Canada, Germany, Puerto Rico
Alkermes, Inc.

Completed

A Drug-drug Interaction Study of ALKS 5461 in Healthy Volunteers

Healthy Volunteers

United States
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH); Virtually Better, Inc.

Completed

Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men (YMSM)

HIV/AIDS | Hiv | Disclosure

United States
Daacro
DuPont Nutrition and Health

Completed

Stress & Anxiety Dampening Effects of a Probiotic Supplement Compared to Placebo in Healthy Subjects

Healthy | Stress, Psychological

Germany
University of Zurich

Unknown

Clinical Application of Sensimed Triggerfish Sensor (TS) With Wireless Signal Transmission for Continuous Intraocular Pressure Measurement

Glaucoma

Switzerland
Mural Oncology, Inc

Completed

A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors

Advanced Solid Tumors

Canada, Spain, United States, Australia, Belgium, Korea, Republic of, Poland
Alkermes, Inc.

Completed

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study

Major Depressive Disorder

United States, Bulgaria
Alkermes, Inc.

Completed

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
First Hospital of China Medical University

Completed

Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias (HPV)

Cervical Intraepithelial Neoplasia | Human Papilloma Virus

China
Tesaro, Inc.

Completed

A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas

Solid Tumors | Lymphomas

United Kingdom, United States, Taiwan, Spain, Poland
Northumbria University
DuPont Nutrition and Health

Completed

The Cognitive Effects of 6 Weeks Administration With a Probiotic

Cognitive Change

United Kingdom
University of Chile

Completed

Effect on Periodontal Markers by Bleaching Intracoronal Technique (BLEIC)

Discolored Teeth
Universidad Europea de Madrid

Withdrawn

Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis

Cystic Fibrosis in Children

Spain
Alkermes, Inc.

Completed

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study

Major Depressive Disorder

United States, Australia, Canada
Imperial College London

Recruiting

The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus (INFLAMMAGE)

RSV Infection

United Kingdom
First Affiliated Hospital of Fujian Medical University

Completed

Study of 18F-Thretide PET/CT in Patients With Prostate Cancer

Prostate Cancer

China
Professor Fernando Figueira Integral Medicine Institute

Withdrawn

Postprandial Walking in Obese Pregnant Women and Perinatal Outcomes - a Multicenter Randomized Clinical Trial

Obesity | Preeclampsia | Gestational Diabetes

Brazil
Janssen Research & Development, LLC

Completed

Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Participants

Healthy

United Kingdom
Azienda Ospedaliero-Universitaria di Modena

Completed

Dialysate Temperature in Peritoneal Dialysis (TPD)

Peritoneal Dialysis Complication

Italy
Alios Biopharma Inc.

Completed

A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176

Respiratory Syncytial Virus Infections

United Kingdom
Alkermes, Inc.

Completed

ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder

Binge Eating Disorder

United States
University of Copenhagen

Not yet recruiting

Building Individual and Community Resilience Through Nature-based Therapies - Case Study 8 Nature for All (RESONATE-CS8)

Mobility Disability
Alkermes, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia

Schizophrenia

United States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
Alkermes, Inc.

Completed

Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function

Renal Impairment

United States
ALK-Abelló A/S

Completed

A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet

Birch Pollen Allergy

Finland, Netherlands

Search clinical trials for: ALKS 37

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations